title: Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000.
abstract: Heparin, hydrogenated dextran sulfate 8000 (Usherdex 8), and dextran sulfate 8000 were administered to rats, and the total drug was separated and determined in endothelium and plasma. A large amount of each drug was recovered from endothelium 2.4 and 6 minutes after intravenous injection. This accounted for the drug missing from plasma. The drugs in water were placed in the stomach by catheter. All three drugs were recovered from the endothelium and identified unchanged by electrophoresis and specific staining. The amounts that were recovered at 2.4 and 6 minutes were equivalent to most of the drug administered. Thus heparin, Usherdex 8, and dextran sulfate 8000 enter the body immediately on oral administration. At longer time intervals after intravenous and oral administration, much of each drug was not demonstrable in endothelium by the method used. Some drug could be detected in endothelium after 4 hours. After oral administration, plasma levels of each drug were rarely more than 0.5% of the dose. Formalin-alcohol was applied to the jugular veins of anesthetized rats to produce a thrombus, (see Blake et al. J Clin Path 1959;12:118-22) and the drugs were immediately introduced into the stomach. Four hours later the injured veins were inspected for thrombi. Incidence of thrombotic plug was 80% in rats that received saline solution, 4% with Usherdex 8, 0% with dextran sulfate 8000, and 0% with heparin. Usherdex 8, dextran sulfate 8000, and heparin demonstrate low, moderate, and high in vitro anticoagulant activity, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Oral Biology, College of Dentistry, University of Saskatchewan, Saskatoon, Canada.
authors.forename: L B
authors.initials: LB
authors.lastname: Jaques
authors.forename: L M
authors.initials: LM
authors.lastname: Hiebert
authors.forename: S M
authors.initials: SM
authors.lastname: Wice
mesh_terms: D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D016264:Dextran Sulfate / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000378:metabolism*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D005753:Gastric Mucosa / Q000378:metabolism*; D006493:Heparin / Q000493:pharmacokinetics* / Q000494:pharmacology; D007275:Injections, Intravenous; D008297:Male; D009994:Osmolar Concentration; D051381:Rats; D011919:Rats, Inbred Strains; D013152:Splanchnic Circulation; D013997:Time Factors
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin; D016264:Dextran Sulfate